Additional experiments showed the presence of an ~50 kDa, n-terminal RIPK1 cleavage product in samples subject to infection with HRV16 (Fig. 2d lanes 2 and 4) but not those subject to infection and treatment with Rupintrivir (Fig. 2d Lanes 6 and 8). This evidence concerns the gene RIPK1 and infection.